BUTITTA CYNTHIA M — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

BUTITTA CYNTHIA M has filed 3 SEC Form 4 filings across 3 companies in the last 90 days.

Profile

Cynthia M. Butitta is a corporate director with experience in the biotechnology sector. She has served on the boards of several companies, including UroGen Pharma Ltd., where she contributes to strategic oversight.

Board memberships

• UroGen Pharma Ltd.
• Century Therapeutics, Inc.
• Olema Pharmaceuticals, Inc.

Awards & honors

• Director at UroGen Pharma Ltd.
• Experience in biotechnology sector
• Board member at multiple companies

Companies — Last 90 Days

• Autolus Therapeutics plc (AUTL) — 1 filings, last 2026-07-01
• UroGen Pharma Ltd. (URGN) — 1 filings, last 2026-06-24
• Olema Pharmaceuticals, Inc. (OLMA) — 1 filings, last 2026-06-23

Frequently Asked Questions

Who is BUTITTA CYNTHIA M?

Cynthia M. Butitta is a corporate director with experience in the biotechnology sector. She has served on the boards of several companies, including UroGen Pharma Ltd., where she contributes to strategic oversight.…

How many SEC Form 4 filings has BUTITTA CYNTHIA M submitted recently?

3 primary Form 4 filings in the last 90 days, covering 3 companies.

Where can I see all of BUTITTA CYNTHIA M's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

• What is SEC Form 4?
• How to read insider buying signals
• Understanding Rule 10b5-1 trading plans
• Browse all insiders
• Most active insiders this week